MCD: Multicentric Castleman's Disease
Multicentric Castleman’s disease with voltage-gated potassium channel antibody-positive limbic encephalitis: a case report
... of MCD is more treatment-resistant than other forms of ...Three-year disease-free survival in HIV-negative pa- tients with plasma cell variant MCD is 45% [17], so our patient’s prognosis remains ...
5
Relapses of primary cutaneous anaplastic large-cell lymphoma in a female immunocompetent patient with persistent chlamydophila pneumoniae and human herpesvirus 8 infection
... ’ s sar- coma (KS), Multicentric Castleman’s Disease (MCD), and Primary Effusion Lymphomas (PEL), and associated to other lymphoproliferative disorders occurring primar- ily in immunosuppresed ...
6
Multicentric Castleman's Disease in a Hepatitis C-Positive Intravenous Drug User: A Case Report
... Castleman’s disease, and to develop a clearer indication of the e ffi cacy of each treatment ...for MCD are currently avail- able and have demonstrated definite clinical improvement and ...
5
Distinct features distinguishing IgG4 related disease from multicentric Castleman's disease
... the two diseases. All the diagnoses were confirmed by pathologists in our hospital. Patients with IgG4-RD satis- fying comprehensive diagnostic criteria but not having pathological confirmation and patients with ...
9
Castleman’s Disease of the Pleura: Case Presentation and Review of Literature
... Castleman’s disease is a lymphoproliferative disorder characterized by enlarged hyperplastic lymph node(s) where there is a polyclonal B lymphocyte proliferation, often associated with autoimmune ...
7
Impact of siltuximab on patient-related outcomes in multicentric Castleman’s disease
... Abstract: Multicentric Castleman’s disease (MCD) is a rare, widespread lymphoproliferative disorder and a life-threatening disease involving hyperactivity of the immune system, excessive ...
7
Detection of Chlamydophila pneumoniae and human herpesvirus 8 in primary cutaneous anaplastic large-cell lymphoma: a case report
... including Multicentric Castleman’s Disease (MCD), Primary Effusion Lymph- omas (PEL) and other lymphoproliferative disorders in immunosuppressed patients ...
5
The Product of Kaposi's Sarcoma-Associated Herpesvirus Immediate Early Gene K4.2 Regulates Immunoglobulin Secretion and Calcium Homeostasis by Interacting with and Inhibiting pERP1
... from multicentric Castleman’s disease (MCD) and Kaposi’s sar- coma (KS) lesions, suggesting that pERP1 may have potential roles in the KSHV life cycle and ...
11
Case Report Clinical and radiological features of parapancreatic hyaline-vascular Castleman disease: a case report and literature review
... Castleman’s disease (LCD), only affects a group of lymph nodes, is defined as a single, benign lesion which usually affects young people [8, ...While multicentric Cas- tleman’s disease (MCD) ...
12
Castleman’s disease in the retroperitoneal space mimicking a paraspinal schwannoma: a case report
... and multicentric CD (MCD) affecting a single lymphatic organ and multiple sites throughout the body, respectively ...Although MCD is less common, it accompanies systemic chronic inflam- matory ...
7
An unusual presentation of Castleman's Disease:a case report
... Hodgkin's disease, non-malignant lymphoma, and an infectious etiology, multicentric Cas- tleman's disease (MCD) remained the likely diagnosis in this ...of MCD with POEMS ...
7
Castleman’s disease in the HIV-endemic setting
... and multicentric have specific systemic manifestations and could be associated with Kaposi sarcoma (KS), Hodgkin’s or non-Hodgkin’s lymphomas, as well as POEMS ...idiopathic MCD, and human ...
11
Primary hyaline vascular Castleman disease of the kidney: case report and literature review
... tleman’s disease; the morphological features of CD mainly manifest as sheets of mature plasma cell infiltra- ...HHV-8-related multicentric types mainly occur in HHV-8-positive and other immunosuppressed ...
6
ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease
... Multicentric Castleman disease (MCD) is a rare entity that, unlike unicentric Castleman disease, involves generalized polyclonal lymphoproliferation, systemic inflammation, and ...
9
A Study on MCD Officials Perception Towards Present Information Sharing Potential in MCD
... of MCD in section ...of MCD officials’ response about present database system is in section ...5, MCD officials’ responses on various motivational factors are ...make MCD more competitive ...
6
Defining and categorizing outcomes of Moral Case Deliberation (MCD): concept mapping with experienced MCD participants
... of MCD, both inside and outside healthcare, and were all very experienced as participants in ...were MCD is ...experienced MCD participants and thus were used to group sessions with equal partici- ...
14
Possible roles of Epstein-Barr virus in Castleman disease
... From January, 1994 to December, 2005, we retrospec- tively reviewed 20 cases with the diagnosis of Castleman disease managed in Mackay Memorial hospital in Taiwan. We retrieved all formalin-fixed, ...
5
Emerging treatments in Castleman disease – a critical appraisal of siltuximab
... Third, there is no current standard for assessing disease response in CD. Although both of the above siltuximab studies adopted some form of the Cheson criteria to define radiologic response, their approaches to ...
7
Unicentric mixed variant Castleman disease associated with intrabronchial plasmacytoma
... unicentric disease is surgical excision, which is usually curative irre- spectively of the histological ...the disease is non- resecable, additional treatments - adjuvant steroid therapy and radiotherapy - ...
6
Unusual Causes of Adenopathy in a Tropical Environment: About 3 Observations
... normocytic anemia at 8.6 g/dl. The liver function test showed a prothrombin level of 50%, a 2-fold hepatic cytolysis and leukocyte alkaline phosphatase of 1.5 times the normal rate. The creatinine serum was 10.5 mg/l ...
8